Commercialization of biobanks a murky issue
![jolab](http://allergen.ca/wp-content/uploads/jolab1.gif)
In a new paper published in the Journal of Law and the Biosciences, Professor Caulfield and co-authors, including AllerGen Research Leaders Drs Allan Becker and Malcolm Sears, explore the challenges of commercializing biobanks for the purpose of advancing medical research and knowledge.
Read how Canadians feel about the commercialization of biobanks here.